Jordan's pharmaceutical exports (medications) grew by 14.8% in 2024 compared to 2023, overcoming the challenges faced by supply chains in the region, which were negatively impacted by the repercussions of the Israeli aggression on the Gaza Strip.
اضافة اعلان
According to Dr. Fadi Al-Atrash, representative of the Pharmaceutical and Medical Supplies Sector at the Jordan Chamber of Industry, Jordan's pharmaceutical exports in 2024 amounted to approximately 611 million Jordanian dinars, compared to 532 million dinars in 2023.
Dr. Al-Atrash stated to the Jordan News Agency (Petra) that the pharmaceutical industry was the second industrial sector to register growth in exports during the past year, reflecting the recovery of companies in the sector from the difficulties they faced due to the unstable conditions in the region.
He added that sector companies were also able to introduce new and innovative drug categories into their production operations, along with growing demand for medicines in neighboring markets. Furthermore, they accomplished many of the sector's enabling goals outlined in the Economic Modernization Vision, particularly regarding registration procedures.
The human pharmaceutical industry in Jordan is considered a cornerstone in the Economic Modernization Vision, supporting the growth of high-value industry exports. It is a productive sector that accounts for about 5% of the total industrial exports in Jordan.
Dr. Al-Atrash emphasized that the human pharmaceutical industry in Jordan is one of the oldest industries in the Arab region, with the first factory established in the city of Salt in 1962. This factory has since become a national product that exceeds borders and gained the trust of export markets. Jordan exports 80% of its pharmaceutical production.
He noted that human pharmaceuticals represent 85% of the total pharmaceutical and medical supplies sector, and today there are 27 facilities across various parts of the country, with a registered capital of approximately 280 million dinars, providing 7,000 direct and indirect jobs, 35% of which are held by women.
Jordanian pharmaceutical exports currently reach 85 markets worldwide, including Saudi Arabia, Iraq, the United States, the UAE, Algeria, and Yemen.
The human pharmaceutical industry sector in Jordan boasts a production capacity of 1.5 billion dinars annually and a successful business model focusing on generic drugs with brand names, a wide range of products, and high international standards.
Jordan produces approximately 4,500 pharmaceutical products, covering a wide range of therapeutic categories, including chronic diseases, oncology, infectious diseases, neurological and psychological conditions, allergies, and gastrointestinal issues.
As for pharmaceutical forms, Dr. Al-Atrash mentioned that Jordan produces tablets, capsules, liquids, drops, sprays, solutions, injections, creams, and many other forms.
He praised the efforts of various official entities, especially the Jordan Food and Drug Administration, in supporting the development of pharmaceutical products through continuous monitoring and the introduction of modern and advanced regulations that have elevated the pharmaceutical industry in Jordan.
Dr. Al-Atrash highlighted the Chamber of Industry’s significant focus on enhancing exports and opening new markets, particularly for pharmaceutical products, through various initiatives, including participation in exhibitions. The latest of these was the participation of Jordanian pharmaceutical companies in the Middle East Pharmaceutical Exhibition held in Saudi Arabia.
He confirmed that the inclusion of the pharmaceutical industry sector in the Economic Modernization Vision reflects its importance as a key contributor to the national economy, aiming to transform Jordan into a regional center for pharmaceutical products, as well as achieving its objectives in pharmaceutical security.
The Economic Modernization Vision includes human pharmaceutical industries as one of its drivers to unleash the potential for future development, aiming to raise the number of workers in the sector to 16,000 by 2033.
The Vision also aims to increase exports by 20.3% annually, reaching nearly 2.1 billion dinars by 2033, up from an estimated 200 million dinars in 2021.
The Vision seeks to attract investments of around 1.1 billion dinars into the human pharmaceutical sector and increase its contribution to the GDP to 1.7 billion dinars by 2033, up from 536 million dinars in 2021.
Among the initiatives proposed by the Economic Modernization Vision for the pharmaceutical industry are attracting investments, improving productivity and cost competitiveness, developing specialized human skills, and establishing simplified pricing mechanisms to ensure price stability. (Petra)
